Marie Linder (M Linder)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Direct Oral Anticoagulants

Respiratory Syndrome Coronavirus

Top Venues

Pharmacoepidemiology and drug safety

Journal of thrombosis and thrombolysis

European journal of epidemiology

Clinical epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Marie Linder, Anders Ekbom, Gunnar Brobert, Kai Vogtländer, Yanina Balabanova, Cecilia Becattini, Marc Carrier, Alexander T Cohen, Craig I Coleman, Alok A Khorana, Agnes Y Y Lee, George Psaroudakis, Khaled Abdelgawwad, Marcela Rivera, Bernhard Schaefer, Diego Hernan Giunta
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study. Journal of thrombosis and thrombolysis 57 (6) (2024)
Stefan de Vogel, John D Seeger, Alejandro Arana, Andrea V Margulis, Lisa J McQuay, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Marie Linder, Ingvild Odsbu, Brandon Suehs, Yihua Xu, Claudia Uribe, Kwame Appenteng, Noah Jamie Robinson
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program. Pharmacoepidemiology and drug safety 33 (5) (2024)
Marie Linder, Anders Ekbom, Gunnar Brobert, Kai Vogtländer, Yanina Balabanova, Cecilia Becattini, Marc Carrier, Alexander T Cohen, Craig I Coleman, Alok A Khorana, Agnes Y Y Lee, George Psaroudakis, Khaled Abdelgawwad, Marcela Rivera, Bernhard Schaefer, Diego Hernan Giunta
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study. Journal of thrombosis and thrombolysis (2024)
Marie Linder, Anders Ekbom, Gunnar Brobert, Kai Vogtländer, Yanina Balabanova, Cecilia Becattini, Marc Carrier, Alexander T Cohen, Craig I Coleman, Alok A Khorana, Agnes Y Y Lee, George Psaroudakis, Khaled Abdelgawwad, Marcela Rivera, Bernhard Schaefer, Diego Hernan Giunta
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study. Journal of thrombosis and thrombolysis 57 (6) (2024)
Sakura Sakakibara, Laura Pazzagli, Marie Linder
Consistency between the National Patient Register and the Swedish Cancer Register. Pharmacoepidemiology and drug safety 33 (4) (2024)
Marie Linder, Anders Ekbom, Gunnar Brobert, Kai Vogtländer, Yanina Balabanova, Cecilia Becattini, Marc Carrier, Alexander T Cohen, Craig I Coleman, Alok A Khorana, Agnes Y Y Lee, George Psaroudakis, Khaled Abdelgawwad, Marcela Rivera, Bernhard Schaefer, Diego Hernan Giunta
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study. Journal of thrombosis and thrombolysis 57 (6) (2024)
Marie Linder, Anders Ekbom, Gunnar Brobert, Kai Vogtländer, Yanina Balabanova, Cecilia Becattini, Marc Carrier, Alexander T Cohen, Craig I Coleman, Alok A Khorana, Agnes Y Y Lee, George Psaroudakis, Khaled Abdelgawwad, Marcela Rivera, Bernhard Schaefer, Diego Hernan Giunta
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study. Journal of thrombosis and thrombolysis 57 (6) (2024)
Stefan de Vogel, John D Seeger, Alejandro Arana, Andrea V Margulis, Lisa J McQuay, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Marie Linder, Ingvild Odsbu, Brandon Suehs, Yihua Xu, Claudia Uribe, Kwame Appenteng, Noah Jamie Robinson
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program. Pharmacoepidemiology and drug safety 33 (5) (2024)
Max Bell, Anders Ekbom, Marie Linder
COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm. European journal of epidemiology 38 (3) (2023)
Max Bell, Anders Ekbom, Marie Linder
COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm. European journal of epidemiology (2023)
Max Bell, Anders Ekbom, Marie Linder
COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm. European journal of epidemiology 38 (3) (2023)
Max Bell, Anders Ekbom, Marie Linder
COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm. European journal of epidemiology (2023)
Joan Fortuny, Gero von Gersdorff, Régis Lassalle, Marie Linder, Jetty A Overbeek, Jonas Reinold, Gunnar Toft, Antje Timmer, Jochen Dress, Patrick Blin, Cécile Droz-Perroteau, Vera Ehrenstein, Carla Franzoni, Ron M C Herings, Bianca Kollhorst, Nicholas Moore, Ingvild Odsbu, Susanna Perez-Gutthann, Cristina Rebordosa, Katherine Rascher, Lawrence Rasouliyan, Kenneth J Rothman, Nuria Saigi-Morgui, Mathias Schaller, Elisabeth Smits, Michael Forstner, null null, Jacques Benichou, Andreas J Bircher, Edeltraut Garbe, David S Rampton, Lia Gutiérrez
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe. Pharmacoepidemiology and drug safety 30 (10) (2021)
Laura Pazzagli, Marie Linder, Johan Reutfors, Lena Brandt
The use of uncertain exposure-A method to define switching and add-on in pharmacoepidemiology. Pharmacoepidemiology and drug safety (2021)
Marie Linder
Using epidemiological methods to quantify the risk of serious infections in children with atopic dermatitis. The British journal of dermatology 185 (1) (2021)
Veena Hoffman, Nina Sahlertz Kristiansen, Marie Linder, Andrea V Margulis, Brandon T Suehs, Alejandro Arana, Kelesitse Phiri, Cheryl Enger, Libby Horter, Ingvild Odsbu, Morten Olesen, Susanna Perez-Gutthann, Yihua Xu, Nina Sahlertz Kristiansen, Kwame Appenteng, Stefan de Vogel, John D Seeger, null null
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study. Drug safety 44 (8) (2021)
Marie Linder, Morten Andersen
Patient characteristics and safety outcomes in new users of ticagrelor and clopidogrel-An observational cohort study in Sweden. Pharmacoepidemiology and drug safety (2021)
Marie Linder, Anastasia Iliadou Nyman, Helle Kieler, Bengt Danielsson, Natalia Borg, Marcus Gry, Julius Collin
Assessing Safety of Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors and Vitamin K Antagonists in Patients with Atrial Fibrillation: A Nation-Wide Propensity Score Matched Cohort from Sweden. Clinical epidemiology 12 (2020)
Mohammadhossein Hajiebrahimi, Ci Song, David Hägg, Therese M L Andersson, Reginald Villacorta, Marie Linder
The Occurrence of Metabolic Risk Factors Stratified by Psoriasis Severity: A Swedish Population-Based Matched Cohort Study. Clinical epidemiology 12 (2020)